NEW YORK (Reuters Health) – Continuing to take low-dose aspirin after endoscopic treatment of a bleeding peptic ulcer raises the risk for re-bleeding but may also reduce mortality…
NEW YORK (Reuters Health) – Giving intravenous drugs during out-of-hospital cardiac arrest does not improve survival, according to a study in the Journal of the American Medical Association…
NEW YORK (Reuters Health) – Adding cetuximab to standard chemotherapy for colorectal liver metastases often shrinks inoperable lesions enough to permit resection, according to a study released today…
NEW YORK (Reuters Health) – Systolic blood pressure, left ventricular (LV) mass, and diabetes status independently predict the likelihood that prehypertensive patients with cardiac risk factors will develop…
NEW YORK (Reuters Health) – Transradial percutaneous coronary intervention (PCI) for acute MI is associated with a lower risk of major bleeding and other adverse events than transfemoral…
NEW YORK (Reuters Health) – Treating HER-2 positive, metastatic breast cancer with trastuzumab significantly increased survival in a retrospective study, to the point were such women given the…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
Patrick Conway, MD, MSc, Chief Medical Officer Policy Division for the Secretary of Health and Human Services, Executive Director Federal Coordinating Council for Comparative-Effectiveness Research at Health and…
Patrick Conway, MD, MSc, Chief Medical Officer Policy Division for the Secretary of Health and Human Services, Executive Director Federal Coordinating Council for Comparative-Effectiveness Research at Health and…
Robert Shorr, Ph.D, D.I.C, CEO, Cornerstone Pharmaceuticals, discusses how physicians can understand a new oncology drug, starting with knowing its safety limitations. He also explains the structure and…
